| Literature DB >> 11553289 |
S J Crocker1, N Wigle, P Liston, C S Thompson, C J Lee, D Xu, S Roy, D W Nicholson, D S Park, A MacKenzie, R G Korneluk, G S Robertson.
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder of the basal ganglia, associated with the inappropriate death of dopaminergic neurons of the substantia nigra pars compacta (SNc). Here, we show that adenovirally mediated expression of neuronal apoptosis inhibitor protein (NAIP) ameliorates the loss of nigrostriatal function following intrastriatal 6-OHDA administration by attenuating the death of dopamine neurons and dopaminergic fibres in the striatum. In addition, we also addressed the role of the cysteine protease caspase-3 activity in this adult 6-OHDA model, because a role for caspases has been implicated in the loss of dopamine neurons in PD, and because NAIP is also a reputed inhibitor of caspase-3. Although caspase-3-like proteolysis was induced in the SNc dopamine neurons of juvenile rats lesioned with 6-OHDA and in adult rats following axotomy of the medial forebrain bundle, caspase-3 is not induced in the dopamine neurons of adult 6-OHDA-lesioned animals. Taken together, these results suggest that therapeutic strategies based on NAIP may have potential value for the treatment of PD.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11553289 DOI： 10.1046/j.0953-816x.2001.01653.x
Source DB: PubMed Journal: Eur J Neurosci ISSN： 0953-816X Impact factor: 3.386